LSTA Lisata Therapeutics, Inc.

NASDAQ
$1.65

Lisata Therapeutics, Inc. (LSTA) is expected to report earnings on November 5, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +47.3% since its last earnings release on August 6, 2026.

Lisata Therapeutics Reported Earnings
Thursday, August 6, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · After Close
Earnings Whisper
-
vs -
Rev est $999
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.56

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Lisata Therapeutics, Inc.

Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.

Sector

Healthcare

Industry

Biotechnology